Form NPORT-P JOHN HANCOCK PREFERRED For: Jan 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Takeda psoriasis drug shows skin clearance in Phase 3 trials
- Crescent Biopharma raises $143.7M in public offering on Nasdaq
- Regenxbio plans $100M common stock public offering
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
